Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Athira Pharma Inc (NASDAQ: ATHA)

 
ATHA Technical Analysis
5
As on 18th Sep 2025 ATHA STOCK Price closed @ 3.83 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1.53 & Strong Buy for SHORT-TERM with Stoploss of 2.35 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ATHASTOCK Price

Open 3.71 Change Price %
High 4.05 1 Day 3.45 907.89
Low 3.66 1 Week 3.45 907.89
Close 3.83 1 Month 3.45 907.89
Volume 100117 1 Year 1.32 52.59
52 Week High 3.43 | 52 Week Low 0.23
 
NASDAQ USA Most Active Stocks
ADAP 0.16 100.00%
AMRS 0.14 100.00%
INTC 30.57 22.77%
WBA 11.98 0.50%
OPEN 9.94 -2.64%
NVDA 176.24 3.49%
BITF 3.20 4.92%
PLUG 2.10 5.00%
CDLX 2.75 92.31%
LMDX 0.02 0.00%
 
NASDAQ USA Top Gainers Stocks
MRIN 3450.00 383233.34%
MRIN 3450.00 383233.34%
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
ATHA 3.83 907.89%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
HCVIU 9.00 159.37%
ARQQW 0.44 144.44%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
OTRK 0.07 -78.79%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
AXDX 0.03 -66.67%
PXSAW 0.01 -66.67%
HPKEW 0.05 -64.29%
TFFP 0.06 -62.50%
 
 
ATHA
Daily Charts		 ATHA
Intraday Charts		 Whats New @
Bazaartrend		 ATHA
Free Analysis
 
ATHA Important Levels Intraday
RESISTANCE4.58
RESISTANCE4.34
RESISTANCE4.19
RESISTANCE4.04
SUPPORT3.62
SUPPORT3.47
SUPPORT3.32
SUPPORT3.08
 
ATHA Forecast September 2025
Share
4th UP Forecast5.47
3rd UP Forecast4.94
2nd UP Forecast4.62
1st UP Forecast4.29
1st DOWN Forecast3.37
2nd DOWN Forecast3.04
3rd DOWN Forecast2.72
4th DOWN Forecast2.19
 
ATHA Weekly Forecast
4th UP Forecast5.20
3rd UP Forecast4.76
2nd UP Forecast4.49
1st UP Forecast4.22
1st DOWN Forecast3.44
2nd DOWN Forecast3.17
3rd DOWN Forecast2.90
4th DOWN Forecast2.46
 
ATHA Forecast2025
4th UP Forecast11.21
3rd UP Forecast8.84
2nd UP Forecast7.38
1st UP Forecast5.92
1st DOWN Forecast1.74
2nd DOWN Forecast0.28
3rd DOWN Forecast-1.18
4th DOWN Forecast-3.55
 
 
ATHA Other Details
Segment EQ
Market Capital 453145184.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ATHA Address
ATHA
 
ATHA Latest News
 
Your Comments and Response on Athira Pharma Inc
 
ATHA Business Profile
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and stop neurodegradation. Its lead product candidate is ATH-1017, a blood brain barrier-penetrating, small hepatocyte growth factor/MET activator that is in LIFT-AD Phase II/III and ACT-AD Phase II clinical trials for the treatment of mild-to-moderate Alzheimer's disease, as well as in clinical development for Parkinson's disease. The company also develops product candidates, which are in preclinical stage, including ATH-1019/ATH-1020 for neuropsychiatric conditions; and ATH-1018 for peripheral nervous system disorders, such as neuropathy. Athira Pharma, Inc. was formerly known as M3 Biotechnology, Inc. and changed its name to Athira Pharma, Inc. in April 2019. The company was incorporated in 2011 and is headquartered in Bothell, Washington. Address: 18706 North Creek Parkway, Bothell, WA, United States, 98011-2141
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service